Sequential evaluation of CALR mutant burden in patients with myeloproliferative neoplasms

por Cavalloni, Chiara, Rumi, Elisa, Ferretti, Virginia V., Pietra, Daniela, Roncoroni, Elisa, Bellini, Marta, Ciboddo, Michele, Casetti, Ilaria C., Landini, Benedetta, Fugazza, Elena, Troletti, Daniela, Astori, Cesare, Cazzola, Mario
Publicado 2017

Clinical course and outcome of essential thrombocythemia and prefibrotic myelofibrosis according to the revised WHO 2016 diagnostic criteria

por Rumi, Elisa, Boveri, Emanuela, Bellini, Marta, Pietra, Daniela, Ferretti, Virginia V., Sant’Antonio, Emanuela, Cavalloni, Chiara, Casetti, Ilaria C., Roncoroni, Elisa, Ciboddo, Michele, Benvenuti, Pietro, Landini, Benedetta, Fugazza, Elena, Troletti, Daniela, Astori, Cesare, Cazzola, Mario
Publicado 2017

Whole-genome CRISPR screening identifies N-glycosylation as a genetic and therapeutic vulnerability in CALR-mutant MPNs

por Jutzi, Jonas S., Marneth, Anna E., Ciboddo, Michele, Guerra-Moreno, Angel, Jiménez-Santos, María José, Kosmidou, Anastasia, Dressman, James W., Liang, Hongyan, Hamel, Rebecca, Lozano, Patricia, Rumi, Elisa, Doench, John G., Gotlib, Jason, Krishnan, Anandi, Elf, Shannon, Al-Shahrour, Fátima, Mullally, Ann
Publicado 2022